Healthcare Jun 28, 2022 09:37 AM (GMT+8) · EqualOcean
Recently, Aibo biology and Jiahe biology jointly announced that they have reached a cooperative development agreement. The two sides will jointly develop globally innovative mRNA products and related drugs. Based on the Jiahe biological antibody development platform and the mRNA technology platform of Aibo biology, the two sides will cooperate in the exploration and research of mRNA drugs for tumor treatment. This is another important cooperation between Aibo biology and newforce after reaching a strategic partnership to jointly carry out the new drug research and development project of lipid nanoparticles (LNP) mRNA delivery for the treatment of retinal diseases, which further demonstrates the development strength of the platform company.